About QuidelOrtho
QuidelOrtho is a company based in San Diego (United States) founded in 1937.. QuidelOrtho has raised $69.05 million across 15 funding rounds from investors including HHS, European Union and Algert Global. The company has 6,600 employees as of December 31, 2024. QuidelOrtho offers products and services including QuickVue COVID-19 Test, Sofia Platform, and Solana Molecular Testing Platform.
- Headquarter San Diego, United States
- Employees 6600 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Quidelortho Corporation
-
Annual Revenue
$2.79 B-6.95as on Dec 31, 2024
-
Net Profit
$-2.05 B-20216.83as on Dec 31, 2024
-
EBITDA
$502 M-28.64as on Dec 31, 2024
-
Total Equity Funding
$69.05 M (USD)
in 15 rounds
-
Latest Funding Round
$20.69 K (USD), Grant
Dec 30, 2021
-
Investors
HHS
& 2 more
-
Employee Count
6600
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of QuidelOrtho
QuidelOrtho is a publicly listed company on the NASDAQ with ticker symbol QDEL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of QuidelOrtho
QuidelOrtho offers a comprehensive portfolio of products and services, including QuickVue COVID-19 Test, Sofia Platform, and Solana Molecular Testing Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Fast lateral-flow test for detecting COVID-19 at home
Benchtop system for rapid diagnostic testing
Platform for faster molecular assays in labs
Unlock access to complete
Software Development Team
119 people
Leadership Team
62 people
Sales and Marketing
56 people
Senior Team
56 people
Finance and Accounting
44 people
Human Resources and Administration
25 people
Product Management Team
25 people
Data Analysis and Operations Team
18 people
Unlock access to complete
Funding Insights of QuidelOrtho
QuidelOrtho has successfully raised a total of $69.05M across 15 strategic funding rounds. The most recent funding activity was a Grant round of $20.69 thousand completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Grant — $20,692
-
First Round
First Round
(11 Sep 2008)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Grant - QuidelOrtho | Valuation |
investors |
|
| Oct, 2021 | Amount | Grant - QuidelOrtho | Valuation |
investors |
|
| Oct, 2021 | Amount | Grant - QuidelOrtho | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in QuidelOrtho
QuidelOrtho has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and Algert Global. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Systematic equity investment firm managing capital for institutional investors globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by QuidelOrtho
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - QuidelOrtho
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Quidelortho Comparisons
Competitors of QuidelOrtho
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Quidelortho
Frequently Asked Questions about QuidelOrtho
When was QuidelOrtho founded?
QuidelOrtho was founded in 1937 and raised its 1st funding round 71 years after it was founded.
Where is QuidelOrtho located?
QuidelOrtho is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of QuidelOrtho?
Douglas Bryant is the current CEO of QuidelOrtho.
Is QuidelOrtho a funded company?
QuidelOrtho is a funded company, having raised a total of $69.05M across 15 funding rounds to date. The company's 1st funding round was a Grant of $3.58K, raised on Sep 11, 2008.
How many employees does QuidelOrtho have?
As of Dec 31, 2024, the latest employee count at QuidelOrtho is 6,600.
What is the annual revenue of QuidelOrtho?
Annual revenue of QuidelOrtho is $2.79B as on Dec 31, 2024.
What does QuidelOrtho do?
QuidelOrtho, backed by 73950786.456085 from European Union, HHS, Algert Global, focuses on providing healthcare solutions, and diversified diagnostics. Provider of healthcare information services. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
What products or services does QuidelOrtho offer?
QuidelOrtho offers QuickVue COVID-19 Test, Sofia Platform, and Solana Molecular Testing Platform.
Is QuidelOrtho publicly traded?
Yes, QuidelOrtho is publicly traded on NASDAQ under the ticker symbol QDEL.
Who are QuidelOrtho's investors?
QuidelOrtho has 3 investors. Key investors include HHS, European Union, and Algert Global.
What is QuidelOrtho's ticker symbol?
The ticker symbol of QuidelOrtho is QDEL on NASDAQ.